Prostatic Cancer, Castration-Resistant
6 clinical trials · Condition
◉ Watch Prostatic Cancer, Castration-Resistant
| Record | Firm | Date |
|---|---|---|
| Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer (NCT04381832) | Arcus Biosciences, Inc. | 2020-07-07 |
| Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) (NCT04157088) | Bayer | 2019-12-17 |
| Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer (NCT04141709) | Technische Universität Dresden | 2019-12-01 |
| Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (NCT02866916) | Institut Claudius Regaud | 2017-09-01 |
Track Prostatic Cancer, Castration-Resistant automatically
Every clearance here is in the API, with alerts when new ones post.